There is a growing awareness that perturbations in glucose/insulin metabolism can contribute to the development of AD, such that AD has been branded “diabetes of the brain” (Nguyen et al., 2020), and there is evidence supporting the anti-diabetic effects of probiotics (Cao et al., 2021). This evidence concerns the gene INS and Alzheimer disease.